{"id":"https://openalex.org/W4361883756","doi":"https://doi.org/10.1158/1078-0432.22452536","title":"Supplemental Table 1 from Dual Targeting of the Type 1 Insulin-like Growth Factor Receptor and Its Ligands as an Effective Antiangiogenic Strategy","display_name":"Supplemental Table 1 from Dual Targeting of the Type 1 Insulin-like Growth Factor Receptor and Its Ligands as an Effective Antiangiogenic Strategy","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361883756","doi":"https://doi.org/10.1158/1078-0432.22452536"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22452536","doi":"https://doi.org/10.1158/1078-0432.22452536","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22452536","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplemental_Table_1_from_Dual_Targeting_of_the_Type_1_Insulin-like_Growth_Factor_Receptor_and_Its_Ligands_as_an_Effective_Antiangiogenic_Strategy/22452536/1/files/39903611.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplemental_Table_1_from_Dual_Targeting_of_the_Type_1_Insulin-like_Growth_Factor_Receptor_and_Its_Ligands_as_an_Effective_Antiangiogenic_Strategy/22452536/1/files/39903611.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111846011","display_name":"Hemant Kumar Bid","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hemant K. Bid","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021474295","display_name":"Cheryl A. London","orcid":"https://orcid.org/0000-0001-8563-1490","observed_orcids":["https://orcid.org/0000-0001-8563-1490"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cheryl A. London","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Jin Gao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jin Gao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075105240","display_name":"Haihong Zhong","orcid":"https://orcid.org/0000-0003-0721-3618","observed_orcids":["https://orcid.org/0000-0003-0721-3618"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Haihong Zhong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109253095","display_name":"Robert E. Hollingsworth","orcid":"https://orcid.org/0000-0003-4470-2920","observed_orcids":["https://orcid.org/0000-0003-4470-2920"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert E. Hollingsworth","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114126225","display_name":"Soledad Fern\u00e1ndez","orcid":"https://orcid.org/0009-0007-7848-9781","observed_orcids":["https://orcid.org/0009-0007-7848-9781"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Soledad Fernandez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015153331","display_name":"Xiaokui Molly Mo","orcid":"https://orcid.org/0000-0002-9797-2687","observed_orcids":["https://orcid.org/0000-0002-9797-2687"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaokui Mo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5109173471","display_name":"Peter J. Houghton","orcid":"https://orcid.org/0000-0002-2400-8184","observed_orcids":["https://orcid.org/0000-0002-2400-8184"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter J. Houghton","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.7583000063896179,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.7583000063896179,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.19269999861717224,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.004000000189989805,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/igf-1-receptor","display_name":"IGF-1 receptor","score":0.9940000176429749},{"id":"https://openalex.org/keywords/igf-ii","display_name":"insulin-like growth factor II","score":0.7269999980926514},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.8569999933242798},{"id":"https://openalex.org/keywords/antibody-therapy","display_name":"antibody therapy","score":0.8119999766349792},{"id":"https://openalex.org/keywords/dual-targeting","display_name":"dual targeting","score":0.6000000238418579},{"id":"https://openalex.org/keywords/pediatric-sarcoma","display_name":"pediatric sarcoma","score":0.9819999933242798},{"id":"https://openalex.org/keywords/xenografts","display_name":"xenografts","score":0.9190000295639038},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.4000000059604645}],"concepts":[{"id":"https://openalex.org/C2780980858","wikidata":"https://www.wikidata.org/wiki/Q110022","display_name":"Dual (grammatical number)","level":2,"score":0.599806547164917},{"id":"https://openalex.org/C45235069","wikidata":"https://www.wikidata.org/wiki/Q278425","display_name":"Table (database)","level":2,"score":0.5234976410865784},{"id":"https://openalex.org/C2780689927","wikidata":"https://www.wikidata.org/wiki/Q24766801","display_name":"Insulin-like growth factor","level":4,"score":0.4591365158557892},{"id":"https://openalex.org/C2781039887","wikidata":"https://www.wikidata.org/wiki/Q1391724","display_name":"Factor (programming language)","level":2,"score":0.4480201303958893},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.43569421768188477},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4042106866836548},{"id":"https://openalex.org/C2775960820","wikidata":"https://www.wikidata.org/wiki/Q408378","display_name":"Growth factor","level":3,"score":0.37425073981285095},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.36466753482818604},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3638843894004822},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33486831188201904},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32816094160079956},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3260161280632019},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3227725625038147},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.2597227692604065},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.1521599292755127},{"id":"https://openalex.org/C124101348","wikidata":"https://www.wikidata.org/wiki/Q172491","display_name":"Data mining","level":1,"score":0.0656767189502716},{"id":"https://openalex.org/C142362112","wikidata":"https://www.wikidata.org/wiki/Q735","display_name":"Art","level":0,"score":0.060230791568756104},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0},{"id":"https://openalex.org/C124952713","wikidata":"https://www.wikidata.org/wiki/Q8242","display_name":"Literature","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.22452536","doi":"https://doi.org/10.1158/1078-0432.22452536","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22452536","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplemental_Table_1_from_Dual_Targeting_of_the_Type_1_Insulin-like_Growth_Factor_Receptor_and_Its_Ligands_as_an_Effective_Antiangiogenic_Strategy/22452536/1/files/39903611.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.22452536.v1","doi":"https://doi.org/10.1158/1078-0432.22452536.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22452536.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22452536","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplemental_Table_1_from_Dual_Targeting_of_the_Type_1_Insulin-like_Growth_Factor_Receptor_and_Its_Ligands_as_an_Effective_Antiangiogenic_Strategy/22452536","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22452536","doi":"https://doi.org/10.1158/1078-0432.22452536","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22452536","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplemental_Table_1_from_Dual_Targeting_of_the_Type_1_Insulin-like_Growth_Factor_Receptor_and_Its_Ligands_as_an_Effective_Antiangiogenic_Strategy/22452536/1/files/39903611.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361883756.pdf","grobid_xml":"https://content.openalex.org/works/W4361883756.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2048625493","https://openalex.org/W4361951121","https://openalex.org/W2164018180","https://openalex.org/W2465495713","https://openalex.org/W2125200558","https://openalex.org/W2032617792","https://openalex.org/W4392723060","https://openalex.org/W4361813296","https://openalex.org/W4318021308","https://openalex.org/W1980328611"],"abstract_inverted_index":{"Supplemental":[0],"Table":[1],"1":[2],"PDF":[3],"file":[4],"56K,":[5],"Comparisons":[6],"of":[7],"time-to-event":[8],"curves":[9],"for":[10],"single":[11],"or":[12],"combined":[13],"antibody":[14],"therapy":[15],"against":[16],"pediatric":[17],"sarcoma":[18],"xenografts":[19],"(listed":[20],"are":[21],"adjusted":[22],"p-values)":[23]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}